跳至主要内容
临床试验/NCT03101150
NCT03101150已完成1 期

Effect of Antenatal Vitamin D3 Supplementation on Risk of Pre-eclampsia

King Fahad Medical City0 个研究点目标入组 179 人开始时间: 2012年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
179
主要终点
Number of Participants With Pre-eclampsia in Both Arms

研究概览

简要总结

Vitamin D deficient pregnant ladies were selected and randomized into 2 groups for routine daily dose of multivitamin (400IU vitamin D3) versus maximum safest treatment daily dose (4000IU vitamin D3). Participants were assessed and compared for number of pre-eclampsia cases.

详细描述

Vitamin D3 has key role in decidualization and implantation of placenta.Vitamin D deficiency is thought to have positive association with pre-eclampsia.Vitamin D deficiency is highly prevalent in some parts of the world and it is not universally screened antenatally. Pre-eclampsia is a known multifactorial pregnancy disorder with significant maternal and perinatal morbidity and mortality. Vitamin D3 has a down-regulating effect on inflammatory pathways and reducing endothelial cell damage.

Investigators want to assess in vitamin D deficient group whether treatment reduces the risk of pre-eclampsia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Confirmed singleton pregnancy of less than 13 completed weeks of gestation at the time of consent.
  • Planned to receive antenatal care in King Fahad Medical City antenatal clinic.
  • The ability to provide written informed consent at the first visit.
  • Low risk pregnancy; and Serum vitamin D3 levels less than < 25nmol/L.

排除标准

  • Mothers with pregnancy with abnormal foetus.
  • Previous history of hypertension, pre-eclampsia, recurrent miscarriages.
  • Chronic kidney disease, chronic liver disease, and malignancy.

研究组 & 干预措施

400 IU Vitamin D3

Active Comparator

400IU vitamin D3 contained in antenatal multivitamin once daily by mouth starting from 14 weeks of pregnancy till delivery.

干预措施: 400 IU Vitamin D3 (Drug)

4000 IU Vitamin D3

Experimental

4000 IU Vitamin D3 drops once daily by mouth starting from 14 weeks of pregnancy till delivery.

干预措施: 4000 IU Vitamin D3 (Drug)

结局指标

主要结局

Number of Participants With Pre-eclampsia in Both Arms

时间窗: From 20 weeks of pregnancy till event of pre-eclampsia seen, whichever came first, assessed up to 32 weeks.

Occurrence of pre-eclampsia or not in all patients irrespective of Vitamin D dose.

次要结局

  • Change in Vitamin D Level(At 36th week of pregnancy)
  • Number of Patients With Intrauterine Growth Retardation(At delivery)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Aisha Mansoor Ali

Assistant Consultant Obstetric and Gynecology

King Fahad Medical City

相似试验